Mar 162016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced changes to its Board of Directors.… => Read more

Five Prime Therapeutics appoints CEO Rusty Williams as Chairman of the Board

From:: Five Prime Therapeutics appoints CEO Rusty Williams as Chairman of the Board

 Posted by at 1:00 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: